Blossomhill Therapeutics, Inc. (BLSM)
26.80
+1.06
(+4.12%)
USD |
NASDAQ |
Sep 21, 16:00
26.13
-0.67
(-2.50%)
After-Hours: 20:00
Blossomhill Therapeutics Enterprise Value : 1.037B for Sept. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 21, 2026 | 1.037B |
| September 18, 2026 | 1.003B |
| September 17, 2026 | 1.037B |
| September 16, 2026 | 1.019B |
| September 15, 2026 | 889.49M |
| September 14, 2026 | 875.82M |
| September 11, 2026 | 847.85M |
| September 10, 2026 | 868.51M |
| September 09, 2026 | 884.09M |
| September 08, 2026 | 913.65M |
| September 04, 2026 | 884.40M |
| September 03, 2026 | 821.15M |
| September 02, 2026 | 800.81M |
| September 01, 2026 | 788.41M |
| August 31, 2026 | 766.48M |
| August 28, 2026 | 806.53M |
| Date | Value |
|---|---|
| August 27, 2026 | 814.16M |
| August 26, 2026 | 771.57M |
| August 25, 2026 | 770.30M |
| August 24, 2026 | 694.33M |
| August 21, 2026 | 705.45M |
| August 20, 2026 | 687.02M |
| August 19, 2026 | 698.78M |
| August 18, 2026 | 696.55M |
| August 17, 2026 | 705.45M |
| August 14, 2026 | 699.10M |
| August 13, 2026 | 704.50M |
| August 12, 2026 | 701.00M |
| August 11, 2026 | 709.90M |
| August 10, 2026 | 693.06M |
| August 07, 2026 | 693.38M |
| August 06, 2026 | 693.38M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IGC Pharma, Inc. | 28.79M |
| Cocrystal Pharma, Inc. | 15.51M |
| CNBX Pharmaceuticals, Inc. | 1.305M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | -17.71M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.76M |
| Total Expenses (Quarterly) | 23.76M |
| EPS Diluted (Quarterly) | -0.7475 |
| Earnings Yield | -8.04% |
| Normalized Earnings Yield | -8.040 |